Spectrum Pharma (SPPI) Misses Q4 EPS by 9c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. BA
6. SPY
7. META
8. HOOD
9. INTC
10. JBLU

Go back to Spectrum Pharma (SPPI) Misses Q4 EPS by 9c, Revenues Beat

Spectrum Pharmaceuticals (SPPI) PT Lowered to $42 at H.C. Wainwright

March 1, 2019 9:02 AM EST

H.C. Wainwright analyst Edward White lowered the price target on Spectrum Pharmaceuticals (NASDAQ: SPPI) to $42.00 (from $43.00) while maintaining a Buy rating.

The analyst commented, "Spectrum reported 4Q18 non-GAAP EPS of ($0.30), versus our estimate of ($0.18) and the consensus non-GAAP estimate of ($0.21). Revenues in the quarter were $29.4... More